Scarica l'app Stockscreener
2.20
5.98%
-0.14
Pre-mercato:
2.14
-0.06
-2.73%
Precedente Chiudi:
$2.34
Aprire:
$2.35
Volume 24 ore:
13,395
Relative Volume:
0.12
Capitalizzazione di mercato:
$27.98M
Reddito:
$2.47M
Utile/perdita netta:
$-13.87M
Rapporto P/E:
-1.8033
EPS:
-1.22
Flusso di cassa netto:
$-12.42M
1 W Prestazione:
-8.33%
1M Prestazione:
-19.12%
6M Prestazione:
-10.57%
1 anno Prestazione:
-51.79%
Intervallo 1D:
$2.20
$2.35
Intervallo di 1 settimana:
$2.18
$2.4426
Portata 52W:
$1.31
$4.99
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CLGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.20 | 29.76M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
Is CollPlant Biotechnologies Ltd. stock dividend yield sustainableTrade Signal Summary & Entry Point Strategy Guides - newser.com
What drives CollPlant Biotechnologies Ltd CPT stock priceEnergy Sector Updates & Rapid Capital Gain - earlytimes.in
Visualizing CollPlant Biotechnologies Ltd. stock with heatmapsEarnings Growth Summary & Short-Term High Return Strategies - newser.com
CollPlant Biotechnologies Ltd. stock prediction for this weekJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Analyzing CollPlant Biotechnologies Ltd. with multi timeframe chartsQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com
CollPlant Biotechnologies (NASDAQ:CLGN) Trading Down 7.6% – What’s Next? - Defense World
CollPlant Biotechnologies Ltd CPT Stock Analysis and ForecastMerger & Acquisition Updates & Market Trend Real-Time Reports - earlytimes.in
Historical volatility pattern of CollPlant Biotechnologies Ltd. visualized2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Why CollPlant Biotechnologies Ltd. stock is trending among retail traders2025 Big Picture & Verified Entry Point Signals - newser.com
Quantitative breakdown of CollPlant Biotechnologies Ltd. recent moveTrend Reversal & Safe Entry Momentum Tips - newser.com
Multi factor analysis applied to CollPlant Biotechnologies Ltd.Earnings Summary Report & Entry Point Confirmation Alerts - newser.com
Tools to assess CollPlant Biotechnologies Ltd.’s risk profileWeekly Stock Summary & Community Driven Trade Alerts - newser.com
How to manage a losing position in CollPlant Biotechnologies Ltd.Weekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year - Yahoo Finance
Comparing CollPlant Biotechnologies Ltd. in custom built stock radarsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Using data filters to optimize entry into CollPlant Biotechnologies Ltd.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com
Collplant stock plunges after advancing dermal filler to clinical trials By Investing.com - Investing.com Nigeria
Collplant stock plunges after advancing dermal filler to clinical trials - Investing.com
CollPlant advances photocurable dermal filler to clinical trials By Investing.com - Investing.com Australia
CollPlant advances photocurable dermal filler to clinical trials - Investing.com India
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - MarketScreener
United States 3D Printed Organ Market Set to Transform - openPR.com
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):